2009
DOI: 10.1002/cmdc.200900072
|View full text |Cite
|
Sign up to set email alerts
|

Asborin: The Carbaborane Analogue of Aspirin

Abstract: Aspirin, the acetyl ester of salicylic acid, was first discovered in the late 1800s and became one of the most world-renowned drugs. Its fame is rooted in its ability to treat a wide range of symptoms such as fever, inflammation, and pain. Aspirin represents an advancement of the previously applied salicylic acid, which was obtained from myrtle leaf decoction or willow bark extract, but was found to be less active and to cause serious gastrointestinal irritation.[1] Later on, other chemical modifications of as… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
44
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 54 publications
(44 citation statements)
references
References 39 publications
0
44
0
Order By: Relevance
“…Asborin was capable of decreasing COX activity, but to a lesser extent than aspirin. [4] However, in the case of AKR1A1, asborin performed far better, and in fact, the cluster was the basis of inhibition. Salicylic acid and aspirin showed only very poor AKR1A1 inhibition, but the cluster analogues were active inhibitors.…”
Section: Mass Analysismentioning
confidence: 97%
See 1 more Smart Citation
“…Asborin was capable of decreasing COX activity, but to a lesser extent than aspirin. [4] However, in the case of AKR1A1, asborin performed far better, and in fact, the cluster was the basis of inhibition. Salicylic acid and aspirin showed only very poor AKR1A1 inhibition, but the cluster analogues were active inhibitors.…”
Section: Mass Analysismentioning
confidence: 97%
“…We previously reported the synthesis of asborin, the carbaborane analogue of aspirin. [4] Asborin inhibits both cyclooxygenase (COX) isozymes, the major pharmaceutical targets of aspirin identified so far. Asborin also proved to acetylate COX-1 and COX-2, but in a completely different manner than aspirin.…”
Section: Introductionmentioning
confidence: 99%
“…Asborin, the carbaborane analogue of aspirin, has a highly hydrophobic cluster framework and hydrophilic carboxyl group and is remarkably amphiphilic: It dissolves in water and nonpolar organic solvents. The pharmacological behavior of asborin was studied [49]. COX inhibition was studied with an enzyme-linked immunosorbent assay (ELISA)-based COX inhibitor screening assay with the free enzymes of COX-1 and COX-2.…”
Section: Carbaboranes As Pharmacophoresmentioning
confidence: 99%
“…Dicarba-closo-dodecaboranes are attractive synthons for developing inorganic pharmaceuticals [1][2][3][4][5][6][7][8], radiopharmaceuticals [9], fluorophores [10], and boron neutron capture therapy (BNCT) [11][12][13][14][15] or synovectomy (BNCS) agents [16,17]. Carboranes are biocompatible, resistant to enzymatic modification, and can be linked to or incorporated within a variety of different targeting vectors.…”
Section: Introductionmentioning
confidence: 99%